Indeed, preclinical studies demonstrate enhanced sensitivity of p53-defective CLL cells to phenethyl isothiocyanate (PEITC), which exacerbates oxidative stress to intolerable levels through induced depletion of cellular glutathione [65,66]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.